Avantor, Inc. (NYSE:AVTR – Free Report) – Analysts at William Blair cut their FY2024 earnings estimates for shares of Avantor in a note issued to investors on Monday, October 28th. William Blair analyst M. Larew now forecasts that the company will post earnings of $0.98 per share for the year, down from their previous forecast of $1.02. The consensus estimate for Avantor’s current full-year earnings is $1.01 per share. William Blair also issued estimates for Avantor’s Q4 2024 earnings at $0.25 EPS, Q3 2025 earnings at $0.30 EPS and Q4 2025 earnings at $0.34 EPS.
Several other research analysts have also recently weighed in on AVTR. TD Cowen boosted their price objective on shares of Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Stifel Nicolaus boosted their price objective on shares of Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Wells Fargo & Company dropped their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Monday. Evercore ISI dropped their price objective on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 2nd. Finally, Morgan Stanley upped their target price on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $27.57.
Avantor Stock Performance
AVTR stock opened at $22.52 on Tuesday. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05. The company has a 50 day moving average price of $25.38 and a 200 day moving average price of $24.22. Avantor has a fifty-two week low of $16.63 and a fifty-two week high of $28.00. The stock has a market capitalization of $15.30 billion, a PE ratio of 57.74, a price-to-earnings-growth ratio of 2.93 and a beta of 1.33.
Institutional Trading of Avantor
A number of large investors have recently made changes to their positions in the company. Graypoint LLC increased its position in shares of Avantor by 3.8% in the 1st quarter. Graypoint LLC now owns 11,414 shares of the company’s stock valued at $292,000 after buying an additional 423 shares in the last quarter. Intech Investment Management LLC increased its holdings in Avantor by 1.8% during the 2nd quarter. Intech Investment Management LLC now owns 29,068 shares of the company’s stock worth $616,000 after purchasing an additional 514 shares in the last quarter. Arizona State Retirement System increased its holdings in Avantor by 0.3% during the 2nd quarter. Arizona State Retirement System now owns 186,567 shares of the company’s stock worth $3,955,000 after purchasing an additional 528 shares in the last quarter. Veracity Capital LLC increased its holdings in Avantor by 1.0% during the 3rd quarter. Veracity Capital LLC now owns 52,359 shares of the company’s stock worth $1,355,000 after purchasing an additional 543 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in Avantor by 2.8% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company’s stock worth $571,000 after purchasing an additional 733 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.
Insider Activity at Avantor
In related news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.50% of the stock is owned by corporate insiders.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Articles
- Five stocks we like better than Avantor
- Dividend Payout Ratio Calculator
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- Financial Services Stocks Investing
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- How to Calculate Retirement Income: MarketBeat’s Calculator
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.